Thursday, October 29, 2026, 1 PM-2 PM ET
Hear an expert discuss the evolving role of PD-L1 testing in HNSCC and ovarian cancer.
Webinar presenter Georgios Deftereos, MD, Professor of Pathology, Associate Director of the Clinical Cancer Genomics Laboratory, Director of Molecular Cytopathology, University of California, San Francisco
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Agilent.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 3, 2026, 1 PM-2 PM ET
Hear an expert discuss the challenges of detecting NRG1 fusions and how RNA-based testing can support more comprehensive fusion identification in clinical practice.
Webinar presenter Benjamin Weinberg, MD, Associate Professor of Medicine and Attending Physician
specializing in gastrointestinal medical oncology
CAP TODAY does not endorse any of the products or services named within. The webinar is made possible by a special educational grant from Diaceutics.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Tuesday, November 10, 2026, 1 PM-2 PM ET
Join us for a session to help improve diagnostic accuracy in your practice when scoring HER2 IHC 0 with faint, incomplete membrane staining in ≤10% of tumor cells vs IHC 0 with no membrane staining detected in patients with mBC.
Webinar presenter Jeffrey Gregg, MD, University of Nevada
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Monday, November 16, 2026, 12:30 PM-2 PM ET
Hear experts discuss a multidisciplinary approach to oncopathology for HER2
assessments for solid tumors in the absence of a companion diagnostic.
Webinar presenters Funda Meric-Bernstam, MD, Chair, Department of Investigational Cancer Therapeutics Medical Director, Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, and Emina E. Torlakovic, MD, PhD, College of Medicine, University of Saskatchewan, Canadian Biomarker Quality Assurance, Saskatoon, Saskatchewan, Canada, and Carol Cheung, MD, PhD, JD, FRCPC, Deputy Director, Canadian Biomarker Quality, Assurance—Programme canadien d’assurance de la qualité des biomarqueurs
CAP TODAY does not endorse any of the products or services named within. This program is being sponsored by Daiichi Sankyo, Inc. and AstraZeneca. The speaker is being compensated for the presentation. The program is not CME accredited and may not be used for CME accreditation.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
October 2014—The Clinical and Laboratory Standards Institute released a new microbiology standard, Principles and Procedures for Detection of Anaerobes in Clinical Specimens; Approved Guideline (M56-A).
October 2014—In its 20th catalog edition, Semrock introduces seven groundbreaking LED light engine filter sets. The sets are optimized for compatibility with the most popular LED-based light engines on the market.
October 2014—Protagen launched its first ELISA research-use test kit, the ADxSSc Multilisa, for systemic sclerosis.
October 2014—SeraCare Life Sciences announced the launch of its Accurun 501 C. difficile Control, the company’s first molecular control product targeting hospital-acquired infections.
October 2014—Quansys Biosciences is releasing Q-Plex Pneumococcal Array (14-plex) for the evaluation and detection of IgG antibody concentrations to pneumococcal polysaccharide serotypes 1, 3, 4, 6B, 7F, 8, 9N, 9V, 12F, 14, a8C, 19A, 19F, and 23F.
October 2014—Thermo Fisher Scientific announced it has completed the sale of its Cole-Parmer customer channel business to private equity firm GTCR for approximately $480 million in cash.
September 2014—Immucor’s PreciseType HEA test is an FDA-approved molecular assay designed to provide clinicians and blood banks with the detailed genetic matching information they need to reduce the risk of alloimmunization and serious hemolytic reactions, which is especially problematic for patients receiving frequent blood transfusions.
September 2014—Wheaton’s CryoElite Tissue Vials are designed for the safe, secure, and effective cryopreservation of biological tissue specimens and are able to maintain sample integrity while maximizing storage capacity and organization. CryoElite Tissue Vials were developed for the high-performance tissue banking requirements of anatomical pathology departments, clinical trial organizations, and biorepository and biobanking facilities.
September 2014—AutoSorter 2000BB is Yaskawa Motoman’s new high-speed bulk sorter for high-volume commercial laboratories. AutoSorter 2000BB provides specimen throughput of up to 2,000 tubes per hour. It minimizes manual handling of specimens through bulk loading and unloading, and reduces sequential sorting by fine sorting in one step.
September 2014—Beckman Coulter Diagnostics showcased five laboratory solutions in its booth, which was themed “New Laboratory Challenges Require New Thinking”: the Power Express automation solution consolidates immunoassay, hematology, and coagulation; the DxH Connected Workcell offers labs workflow management while delivering comprehensive and accurate patient results; the latest addition of the IRIS International urinalysis portfolio; the Remisol Advance enterprise data management system; and its immunoassay diagnostic testing menu, which includes AccuTnI+3 troponin I in the cardiac panel, the Prostate Health Index (phi) as part of the men’s health panel, and a complete reproductive panel.
